TC BioPharm's Grant - III Round

TC BioPharm raised a round of funding on August 03, 2017. Investors include Horizon 2020.

TC BioPharm is an immunotherapy and clinical development company with a cell-based product pipeline capable of treating a variety of disorders including cancer and severe viral infections. Its lead pr…

Articles about TC BioPharm's Grant - III Round: